Cargando…
Cholesterol levels of Japanese dyslipidaemic patients with various comorbidities: BioBank Japan
BACKGROUND: Controlling serum cholesterol is critical to prevent cardiovascular disease in patients with dyslipidaemia. Guidelines emphasise the need to select treatment for dyslipidaemia based on specific patient profiles; however, there is little information about the serum cholesterol levels of p...
Autores principales: | Yokomichi, Hiroshi, Noda, Hokuto, Nagai, Akiko, Hirata, Makoto, Tamakoshi, Akiko, Kamatani, Yoichiro, Kiyohara, Yutaka, Matsuda, Koichi, Muto, Kaori, Ninomiya, Toshiharu, Kubo, Michiaki, Nakamura, Yusuke, Yamagata, Zentaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5350591/ https://www.ncbi.nlm.nih.gov/pubmed/28196738 http://dx.doi.org/10.1016/j.je.2016.12.014 |
Ejemplares similares
-
Statin use and all-cause and cancer mortality: BioBank Japan cohort
por: Yokomichi, Hiroshi, et al.
Publicado: (2017) -
Serum glucose, cholesterol and blood pressure levels in Japanese type 1 and 2 diabetic patients: BioBank Japan
por: Yokomichi, Hiroshi, et al.
Publicado: (2017) -
Survival of macrovascular disease, chronic kidney disease, chronic respiratory disease, cancer and smoking in patients with type 2 diabetes: BioBank Japan cohort
por: Yokomichi, Hiroshi, et al.
Publicado: (2017) -
Risk prediction models for mortality in patients with cardiovascular disease: The BioBank Japan project
por: Hata, Jun, et al.
Publicado: (2016) -
Characteristics of patients with liver cancer in the BioBank Japan project
por: Ukawa, Shigekazu, et al.
Publicado: (2017)